Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Wallace Rheumatic Study Center is a premier clinical research facility and medical practice based in Los Angeles, California, specializing in the diagnosis, treatment, and study of autoimmune and inflammatory diseases. Founded by Dr. Daniel J. Wallace, a world-renowned expert in lupus, the center serves as a critical site for high-impact Phase 1 through Phase 4 clinical trials. It focuses on advancing therapies for conditions such as systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome. The center is recognized for its extensive patient registries and its significant contributions to the clinical development of numerous FDA-approved rheumatologic treatments. By integrating clinical care with cutting-edge research, the center provides patients with access to novel therapeutic modalities including monoclonal antibodies and small molecule inhibitors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wallace Rheumatic Study Center.